Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire HKSTP Elite Global Inno Day Showcasing Impactful Innovations from Future Unicorns
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Media-OutReach Newswire AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license
Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
Probe into student’s death reopened following father’s actions, possible traffic iiolations suspected 4.